港股创新药板块持续下挫
Di Yi Cai Jing·2026-02-26 10:36Group 1 - The stock prices of BeiGene fell over 8%, WuXi Biologics dropped over 7%, and Tigermed and CR-CCM both declined over 5% [1] - Other companies such as Junshi Biosciences, WuXi AppTec, and Innovent Biologics also experienced declines in their stock prices [1]